The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EHA 2024 | The rapid evolution of myeloma research & the importance of improving drug accessibility
Meral Beksac, MD, PhD, Istinye University Ankara Liv Hospital, Ankara, Turkey, discusses the rapid evolution of multiple myeloma research. She highlights how new data continually emerges, making it difficult to finalize treatment guidelines. She emphasizes the importance of developing effective and accessible drugs and calls for a deeper understanding of the disease’s biology, including the factors controlling it intrinsically and extrinsically. This interview took place at the 29th Congress of the European Hematology Association (EHA) in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
